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Current experiments touch only small but overlapping parts of very complex subcellular
signaling networks in neurons. Even with modern optical reporters and pharmacological
manipulations, a given experiment can only monitor and control a very small subset of
the diverse, multiscale processes of neuronal signaling. We have developed FindSim
(Framework for Integrating Neuronal Data and SIgnaling Models) to anchor models to
structured experimental datasets. FindSim is a framework for integrating many individual
electrophysiological and biochemical experiments with large, multiscale models so as to
systematically refine and validate the model. We use a structured format for encoding
the conditions of many standard physiological and pharmacological experiments,
specifying which parts of the model are involved, and comparing experiment outcomes
with model output. A database of such experiments is run against successive
generations of composite cellular models to iteratively improve the model against each
experiment, while retaining global model validity. We suggest that this toolchain provides
a principled and scalable way to tackle model complexity and diversity of data sources.
Keywords: simulation, signaling pathway, systems biology, biochemistry, pharmacology, LTP, synaptic signaling
INTRODUCTION
Neuronal signaling is a complex, multiscale phenomenon which includes genetic, biochemical,
transport, structural, protein synthesis, electrical and network components. There is an abundance
of models of specific parts of this landscape, with a special focus on electrophysiological properties
of neurons (Hodgkin and Huxley, 1952; Bhalla and Bower, 1993; De Schutter and Bower, 1994;
Narayanan and Johnston, 2010) and biochemical signaling in plasticity (Lisman, 1985; Bhalla
and Iyengar, 1999; Shouval et al., 2002; Hayer and Bhalla, 2005; Smolen et al., 2006; Kim et al.,
2010; Manninen et al., 2010; Li et al., 2012; Stefan et al., 2012). Each of these models has its own
parameterization idiosyncrasies, and even when the data sources are described in some detail (e.g.,
Bhalla and Iyengar, 1999) the derivation of specific rate terms and parameters is something of an
individualistic art form. Further, each of these models typically incorporates far more knowledge
about the biological system than is apparent from a plain listing of data sources. While this
has resulted in high quality, hand-crafted models for specific processes, there are several major
drawbacks of this almost universal modeling process. First, it is idiosyncratic. Second, most models
are highly specific for individual questions posed by the developers. Third, by necessity, all such
models are tiny subsets of known signaling (Heil et al., 2018). Fourth, models rarely venture across
scales, that is cross electrical and biochemical, or structural and genetic.
There are some counter-currents to this highly personalized modeling process. The first has
been the emergence of a range of standards for model specification (Hucka et al., 2003; Gleeson
et al., 2010), experiments (Waltemath et al., 2011; Garcia et al., 2014; Teeters et al., 2015), andmodel
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output (Ray et al., 2016). The continued development of
community-based standards is overseen by the COMBINE
initiative (Hucka et al., 2015). These standards mean that even
though individual model development may remain personalized,
models can be much more readily shared. Numerous databases
now host such models (Migliore et al., 2003; Sivakumaran et al.,
2003; HarshaRani et al., 2005; Le Novère et al., 2006; Gleeson
et al., 2015). With this set of resources, the models, simulation
experiments performed on them, and their output, can each be
specified in a platform-neutral and unambiguous manner.
A second recent development has been the emergence of
simulators designed for multiscale signaling (Ray and Bhalla,
2008; Wils and De Schutter, 2009) as well as the incorporation of
multiscale features in existing simulators (Bhalla, 2002b; Brown
et al., 2011; McDougal et al., 2013). With these developments
the most common scale crossover, between spatially detailed
electrical and chemical models, is greatly facilitated.
A third major counter-current to this highly personalized
modeling process is the development of model specification
pipelines. The CellML project has developed data pipelines
for model composition, annotation, model reduction and
linkage to databases (Beard et al., 2009). The Allen Brain
Project (Gouwens et al., 2018) and the Human Brain Project
(Markram et al., 2015) have each developed systematic approach
to parameterizing neuronal models, and the availability of
such open resources has enabled development of independent
efforts for experiment-drivenmodeling workflows (Stockton and
Santamaria, 2017). These models build on previously developed
ion-channel specifications and the parameter tuning is typically
by way of assigning experimentally-driven passive properties
and scaling channel densities, both in reduced and in detailed
cellular morphologies. There are several related approaches to
specify experimental data and metadata. For example, Silva
and colleagues (Silva and Müller, 2015; Matiasz et al., 2017)
have come up with frameworks for defining neurobiological
experiments. Much more structured experiments such as
microarrays (Brazma et al., 2001), next-generation sequencing,
e.g., (Kent et al., 2010) or proteomics (Taylor et al., 2006,
2007) have their own metadata formats. In neuroscience, several
such initiatives exist, for various types of neurobiological data
(Garcia et al., 2014; Rübel et al., 2016; Stead and Halford, 2016).
These specification formats are very powerful ways to ensure
experimental consistency and reproducibility. However, our
objectives were distinct, and more restricted, in two important
ways. First, we needed not to reproduce experiments, but to be
able to map them to simulations. Second, we needed to do this
for a wide range of ‘‘legacy’’ style experiments, where structured
metadata was neither available, nor easily specified. We therefore
selected a small core subset of metadata and experimental data of
direct relevance to simulation development.
The current study examines how to systematically use
experimental data to parameterize multiscale neuronal signaling
models reproducibly, scalably, openly, and in a generally
applicable manner. It is clearly desirable to have a standard
for facile mapping between experiments and models, especially
in the rapidly expanding domain of neural physiology and
signaling. We envision the role of FindSim as a first key
step towards a standard, by demonstrating a functional
implementation of experiment-driven simulation specification in
a production environment. We examine the requirements for
such an eventual standard by exploring a diverse and challenging
set of use cases. We report two core developments: how to
unambiguously and scalably match experimental observations
to models, and how to manage development of very large
models having thousands of components needing thousands of
experimental constraints. Both are combined in FindSim, the
Framework for Integration of Neuronal Data and SIgnaling
Models. We explain FindSim and illustrate a model development




We illustrate our approach using a large core model of
biochemical signaling which is designed to be embedded
in a single-compartment electrical model (Figure 1). The
biochemical model has over 300 molecular species and a similar
number of reactions and is drawn from several neuronal
signaling models (Bhalla and Iyengar, 1999; Hayer and Bhalla,
2005; Jain and Bhalla, 2009). While large by current standards,
this model is, of course, far from the current known complexity
of synaptic signaling (Bayés et al., 2011; Heil et al., 2018).
Even though reduced, the current models explore many of the
technical challenges for model specification that will arise in
more complete future models and serve as a good test-bed for
the current analysis.
Based on experience with development of neuronal signaling
models, both within our groups and from the published
literature, we chose three categories of experiments for our initial
set. These were time-series, dose-response and multi-stimulus
response. It was our observation that a large fraction (typically
well over half) of data panels from the articles that were used
for prior model development studies in this domain (Bhalla and
Iyengar, 1999; Shouval et al., 2002; Lindskog et al., 2006; Stefan
et al., 2008; Kim et al., 2010) fell into these three categories. As
such, these were easy targets with substantial value for model
development. Further, we were able to generalize effectively
within each category. For example, there are many variations
of dose-response experiments. These may use different initial
conditions, different ways of controlling the stimulus (dose),
absolute or relative scaling for measuring the response, and so
on. These variations were readily accommodated within our
framework. As we discuss below, this approach also generalizes
to the electrophysiological domain, and commonly used current
and voltage-clamp experiments also fall into this framework.
Model Development and Parameterization
Pipeline
The first of the core advances in this study is the definition of a
model development and parameterization pipeline that takes the
model and subjects it to a battery of experimental tests, defined
in an open, extendable and structured form. In brief, any of a set
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FIGURE 1 | Signaling model and experiments on it. (A) Block diagram of model. (B) Expanded reaction scheme for one of the reaction blocks. The experiments
typically act on similar small subsets of the full model. (C–F): Typical kinds of experiments on the model. (C) Time-series experiment with stimulus pulse
(brain-derived neurotrophic factor (BDNF), blue) leading to signaling response (TrkB receptor activation, black). (D) Dose-response experiment, where defined BDNF
stimuli lead to receptor activation. (E) Schematic of drug interaction experiment, where different combinations of stimuli are examined for their response, as shown by
the bar chart. (F) Schematic voltage trace following a step current clamp stimulus.
of models is simulated according to instructions derived from the
experimental dataset, and the outcome for each such simulation
is scored according to how well the model fits the data. The
models may be variants of the reference model, updated with
progressively improved parameters or reaction schemes. They
may also be specifically altered ‘‘mutant’’ or ‘‘disease’’ versions of
the reference, for example, representing known mutants through
the loss of a given molecular species. Our reference model is a
composite of several modeling studies linked together based on
known interactions.
Each structured experiment entry in the dataset is drawn
from one of the three categories illustrated above: time-series,
dose-response, or multi-stimulus response (Figure 1). The
∼40 experiments in our initial database are all variants of
these three categories, though further categories can readily be
implemented. The experiment definitions specify which part of
the model to use, which stimuli to deliver, and what results to
expect (Figures 2, 3). The structured form of these definitions
makes them independent of the exact model implementation.
To run through the models, we have implemented a Python-
based script that reads the model and experiment definitions
and launches the MOOSE simulator to execute the experiment.
This wrapper script then examines the outputs fromMOOSE and
compares these with those expected from experiment (Figure 2).
This comparison is scored according to a user-defined scoring
function specified as part of the experiment definition. In
order to improve cross-platform testability, the pipeline can also
generate an SBML file for execution of the model on alternate
platforms. This SBML file contains the model definition for
that subpart or version of the reference model upon which the
experiment is carried out, and where feasible, the definition of
the stimulus that is applied to the model.
Stepping back, this entire pipeline can be run successively with
different models, different experiments, and different scoring
schemes. This is an embarrassingly parallel problem, so it is
relatively easy to decompose the entire experiment set onto
different processors on a cluster. Further, the structure of the
scoring pipeline lends itself to an optimization step (dashed line
in Figure 2) in which the model parameters are tweaked to
improve the match to experiment as reflected in the model score.
In summary, we have implemented a model, a database
and structure for experiment specification, and a pipeline to
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FIGURE 2 | Block diagram of the FindSim pipeline. Top: the inputs to the pipeline. Left: Model specification, typically in SBML. Middle: experimental stimuli. Right:
experimental outcomes. Middle from top: the two experimental inputs and the metadata for how to apply these to the model are specified in a structured experiment
definition in a tab-separated text file (.tsv file). This may be manipulated by an enhanced spreadsheet, or through a GUI. Below: the experiment definition and model
are read in and executed by a Python/MOOSE script. This may either run the simulation and compare with experiment (right, lowermost) or emit SBML output so
that the experiment can be run on other simulators. There are options to utilize the score from the simulation comparison as part of a model optimization cycle.
systematically test the model against each experiment. Each of
these is in an open format and is accessible for other models and
simulation tools1.
1https://github.com/BhallaLab/FindSim
Experiment Specification and Mapping
The second core development in this study is a methodology
for mapping experiments to large models. The conceptual
challenge is how to merge many pathway-specific readouts into a
consistent, cell-wide model. One could do so either by assembly
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FIGURE 3 | Components of experiment specification. (A) Experiment
metadata, including citation information and authorship. (B) Experimental
context, including species, preparation and conditions. (C) Stimulus
information such as molecular identity and concentration of a pharmacological
agent. (D) Readouts from the experiment, such as a gel or time-course, each
representing a set of measurables that should have a direct mapping to the
model.
of small models into a large composite one, or by extraction
of small sub-models from the reference composite model. The
first approach maps closely to the individual experiments and
modular perspectives of pathway function (Bhalla and Iyengar,
2001). We have described composition of large models from
small modules for the first approach in previous work (Bhalla,
2002a), but with a topological rather than parameterization
emphasis. The second approach incorporates interactions and
takes a systems-level view.
The problems with the first approach are: (a) it is just as
important and difficult to parameterize interactions between
pathways as it is to parameterize the pathways themselves; (b)
modifications to one pathway are likely to have knock-on effects
on many others. The second approach (which we adopt here)
handles pathway modularity by running the experiment on just
that sub-portion of themodel that is addressed in the experiment.
It addresses point (a) by building in the pathway interactions into
the composite model. This facilitates model comparison with
experiments that span interacting pathways, and hence provides
a process to parameterize the interactions. It does pose a specific
technical issue of cleanly extracting small sub-models from the
large one, which is addressed below. Point (b) remains relevant
even in the second approach using a composite model. However,
the larger model is amenable to ‘‘clean-up’’ of knock-on effects
by running through all the subsequent experiments to fine-tune
sub-models that may be impacted by the original change.
We now describe the structured experiment definition that
implements the mapping of experiments to a large composite
model (Figure 3). The goal of this definition is to provide a
standardized, model-independent specification of experimental
context, inputs, observed experimental results, and support for
mapping each of these to model definitions. Some portions
of such a definition have been formalized in the Simulation
Experiment Definition Markup Language (Waltemath et al.,
2011). Other aspects have been implemented in individual
projects (Wolstencroft et al., 2017). SBML itself has support
for delivery of specific inputs within the model definition
markup file (Hucka et al., 2003). To our knowledge there
is no unified specification standard that supports all of the
elements essential to developing a model pipeline of the kind we
envisage.
The key parts of the structured experiment definition are:
(1) Experiment metadata. This specifies who did the experiment,
citations, and other context. (2) Experiment context. This
specifies species, cell-types, sample extraction methods, and the
pathways expected to be relevant to the experiment. It also
includes temperature, pH and other conditions pertinent to
reproducibility. (3) Stimuli. These are the specific manipulations
performed in the course of the experiment. This section can
be quite diverse, and currently represents three main classes of
experiments (Figure 1). For example, in the case of a time-series
experiments, the inputs section would specify which molecule(s)
were added to the preparation, at what times, and at what
concentration. (4) Readouts. These are the readouts from the
experimental preparation. This too is specific for each class of
experiment. For example, in a time-series experiment the output
would specify which molecule(s) were monitored, the observed
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concentration, and where available, the standard error for each
observation.
The above four sections are all purely in the experimental
domain and could in principle be filled in without any reference
to the modeling. Part 5 (Model mapping) is special in that it
explicitly sets up the mapping of experimental entities to model
entities. Several of these are straightforward, such as identifying
the mapping between input/output molecules in the experiment
and in the model. The crucial and novel part of the experiment
definition is the extraction of the relevant pathways from
the composite model. While the experimentalist will provide
some indication of the relevant pathways when describing the
experiment (Figure 3B), it requires some understanding of
model structure to formally define which pathways should be
used. In brief, we impose a hierarchical organization onto
our reference composite models, thus facilitating grouping
of molecules and reactions into pathways, and even further
groupings of related pathways into larger pathway circuits. In
most experiments, the extraction of sub-models is a simple
matter of specifying which pathways need to be used. Further
fine-tuning of the sub-model may involve addition or removal
of specific molecules or reactions from the final subset for
extraction (Figure 4). In the current implementation, the
extracted subset is defined as a string in the familiar directory/file
format, which is also similar to the XPATH format used in XML.
While this key step is conceptually simple, the
implementation of pathway extraction has a number of
subtleties (Figure 4B). First, there is the problem of ‘‘dangling’’
reactions, which occur when model extraction has removed one
or more of the substrates of a reaction. This admits of a technical
solution by way of explicit tests and warnings for such situations.
Second, extracted pathways may lose key regulatory inputs,
leading to uncontrolled build-up of signals at run-time. This
requires human inspection of the outcome of each experiment,
and subsequent reconsideration of the extraction procedure.
Third, experimental conditions frequently modify the base
model not just by removal of pathways, but also by addition
of buffers and inhibitors to the medium. This is addressed by
expansion of Part 5 of the experiment specification to include
such manipulations. Fourth, the mapping of experiment to
model entities is not always clean. For example, there may be
multiple protein isoforms in the experiment, the model, or both.
In essence, this is a problem of model detail, and the modeler and
experimentalist have to get together to decide the appropriate
mapping, given the detail in any given composite model.
One of the key design decisions for the current pipeline
implementation was not to try to automate too much of the
mapping of entities that comprises part 5 of the experiment
definition. For example, one could envisage using extensive
Gene Ontology (GO) markup of each pathway or molecule
to automatically obtain the appropriate mapping between
experiment and model (Ashburner et al., 2000). This is the
approach taken in existing tools for model merging (Neal et al.,
2015), model feature extraction (Alm et al., 2015; Neal et al.,
2015), or combination of models with experimental datasets
(Cooper et al., 2011) based on semantic annotation. All those
tools rely on high-quality expert annotation. For our purposes,
FIGURE 4 | Specification of model sub-parts. (A) Original full model, from
which a few pathways are selected. (B) Further selections of reactions from
the subset of pathways. Deleted molecules, reactions, and enzymes are
indicated by boxes with blue crosses. In some cases, deleting molecules
leads to dangling reactions (red dashed boundary), which lack one or more
reactants. The system identifies these. In addition to removal of extraneous
reactions and reactants, the experiment specification may involve alteration of
parameters, such as the concentration of a molecule that is buffered in the
experiment. This is illustrated as orange boxes around the molecule TOR_clx.
Finally, the model specification also defines the mapping between the
experimental names for stimulus or readout molecules, to the corresponding
names for these molecules as used in the model.
our analysis was that the GO, or any other markup, would
typically fall short of specifying all the details of experiments
or model implementation. Thus, in practice one would almost
always have to layer on further explicit specification of entities,
and thus have to fall back on some more complicated version
of our current ‘‘part 5’’. We also felt that extensive GO
annotation from the outset would impose a further burden on the
experimentalist as well as on anyone adapting existing models.
This effectively means that part 5 of the experiment definition
requires curation by human experts. This is an opportunity for
experimentalists and modelers to collaborate and provides a
framework for clarifying assumptions on both sides and reaching
agreement on the model. It is also worth noting that once this
work has been done once for a specific combination of sub-model
and experiment, it can be used for testing and validating future
versions of the model.
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FIGURE 5 | Components of the structured specification of experiment and its mapping to the simulation, implemented as a spreadsheet. In all sections the top line
specifies a block of data, and the left column specifies fields to fill in that block. All fields and block titles support tool-tips, that is, pop-up help windows with an
explanation of the block and field. These are illustrated here as speech balloons. Fields having a restricted set of options, such as quantity units, are specified with
pull-down menus. In several cases there are tabulated sections, which contain value-range limited entries and which can be extended for additional data points.
(A) Experiment metadata section. This specifies data about the experiment source and who transcribed it. A menu item is illustrated for the “exptSource” field.
(B) Experiment context section. This specifies biological context for the experiment. (C) Stimuli. This section specifies inputs that were given during the experiment:
which entity or molecule to change, which parameter was altered, and finally a series of time-value pairs that specifies the stimulus. (D) Readouts. This specifies
which entities (such as molecules) were monitored during the experiment, and what values were obtained at each readout time. It may include error bars for each
value. (E) Model mapping. This section is the only model-specific part. It indicates a reference model for which the experiment was first tested. For that model it
specifies how to obtain the appropriate subset of pathways, molecules and other model entities to use in the simulated “experiment”. The model map next specifies
which numerical methods to use. There follows a dictionary of entity names, which maps the experimenter’s naming scheme to unique entity names in the
simulation. Finally, there is a table of parameters that have to be changed so that the model matches the experimental conditions. For example, some of the
molecules in the experiment may now be buffered to specified values.
Having determined the components of the structured
experiment specification, we next explain its implementation.
Drawing upon lessons from existing projects that implement
some parts of these requirements (Wolstencroft et al., 2011,
2017), we chose an enhanced spreadsheet interface as our
initial interface (Figure 5). Our interface is implemented and
exported in Google Docs2 and additional versions are provided
for Microsoft Excel and Open Office. The contents of these
spreadsheets are exported to tab-separated value (tsv) files for use
by FindSim. We provide a schema for these tsv files3.
There were several reasons for a first implementation as a
spreadsheet. First, spreadsheets are easy to set up and familiar
2https://www.ncbs.res.in/faculty/bhalla-findsim/worksheet
3https://github.com/BhallaLab/FindSim
to users. Our spreadsheet interface supports key features such as
bounds checking on entered data, for example to ensure that only
positive values are used. It also supports pull-downmenu options
for restricted choices, such as concentration units. Explanatory
tool-tips are readily incorporated to provide immediate online
help. Spreadsheets are inherently extendable with additional
data rows or columns and can easily export data into the
standard tab-separated value (tsv) format we use for driving the
simulations. Finally, spreadsheets are highly portable, including
in the cloud.
Based on a pilot set of ∼40 experiments, we have found
that a large range of biochemical experiments can be specified
with just three kinds of very similar spreadsheets: time-series,
dose-response, and multi-stimulus response. In all cases there
are identical panels for experiment metadata and context. There
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are slightly specialized blocks for experimental stimulus and
readouts. The final, model mapping panel (Figure 5E) is again
almost identical. This framework is easily extended to further
kinds of experiments, including electrophysiological and imaging
data.
In summary, we have designed and implemented a framework
for specifying the design and outcomes of experiments in a form
which maps directly to corresponding simulation experiments.
This supports validation, scoring and optimization of models.
The key innovations are formalization of a wide range of
experiments and a procedure for defining how to extract parts
of a large model that are necessary and sufficient to account for
any given experiment.
Example of Data Flow Through the Pipeline
We now illustrate the data flow through the pipeline (Figure 2)
using a specific example of a pre-existing model, and an
experiment to be applied to it (Figure 6). The stages in the
pipeline are:
1. Model specification. In this case the model specification is a
pre-existing SBML file.
2. Experimental details. The experiment is a straightforward
stimulus-response experiment in which the 40S subunit of
the translation complex is applied to a solution with a known
amount of eIF4E-mRNA, and the formation of 43S subunit is
monitored.
3. Mapping between experiment andmodel. As the experimental
pathways are a small subset of the larger model, we select a few
relevant pathways, and further we remove from the pathway
models those reactions that are not present in the experiment.
4. Simulation control. Here we take those molecules that are
buffered in the experiment and change the model accordingly.
We then run the simulation, applying the stimulus to one of
the molecules at the specified times.
5. We now compare experiment and simulation readouts, using
a scoring equation defined in themodel mapping section from
Figure 5.
6. At this stage we could use the score to do a local optimization
of parameters using manual or automated optimization. This
would give us a version of the main model where the
local parameters for this pathway have been matched to
experiment.
7. We now repeat steps 2 to 6 for different experiments, to obtain
a global score for the model. Additionally, local optimizations
will need validation from experiments that involve larger
subsets of the overall model.
At the end of this process, we will have a model that is a
better fit to specific experiments, and we also have a score that
can be given to the model as a whole. Note that it is entirely up
to the modeler-experimentalist team to decide how much weight
should be given to different experiments.
Cross-Experiment Model Reproducibility
A key goal of the FindSim pipeline is to expose models to a range
of experiments so that the model is a good fit to all of them, not
just a single case. This is a particularly tough constraint when
FIGURE 6 | Data flow using the model specification, experiment specification,
model subset extraction, simulation and comparison with output.
we have multiple experiments that probe responses of the same
and overlapping signaling pathways. In this section we describe
how the model database can include just this kind of overlapping
experiment, to show how the modeler and experimentalist can
together examine reproducibility and generalizability of the core
model.
Here we focused our attention on the MAPK signaling
pathway. We first considered reproducibility of the core part
of this pathway, in which MAPK is stimulated by an epidermal
growth factor (EGF) signal in PC12 cells (Figure 7A, green
boundary; Teng et al., 1995). The simulation approximates
the experiment quite closely (Figure 7B). We next illustrate a
fundamental limitation on being able to reproducibly fit data:
the observation that different experiments with very similar
contexts may give mutually inconsistent results (Figures 7B,C).
We then considered experiments involving overlap of the
core (MAPK) pathway but distinct input signaling via brain-
derived neurotrophic factor (BDNF) in E18 primary embryonic
hippocampal neurons (Ji et al., 2010). In the case of BDNF, the
core model behavior of a transient strong response followed by
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FIGURE 7 | Reproducibility example: multiple experimental inputs converging onto a common signaling pathway (MAPK). (A) Block diagram of composite model.
Sub-models for the different inputs are indicated in green (epidermal growth factor, EGF), red (BDNF) and blue (Calcium). (B) Response to EGF stimulus is a transient
activation of MAPK. Model (dashed green line) closely follows experimental curve (solid green line). (C) Response to EGF in similar preparation but lower dose. Note
that the simulated peak response is higher than experiment in (B), but lower in (C), leading to difficulties in model fitting. (D) Response to BDNF stimulus is also a
transient, but the time-course of MAPK signaling in this experiment is much longer than it was in panel (B). (E) Response to an LTP-induction stimulus for calcium,
consisting of three pulses separated by 600 s. Here the reference is an earlier simulation predicting sustained activation of MAPK. Remarkably, there is a reasonable
match to the reference behavior in all three cases, despite the inputs converging onto the MAPK pathway through different signaling pathways, and the results drawn
from very different data sources.
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a sustained low response was preserved, but the time-courses
and the intervening stages were quite different. Again, the model
performed reasonably well in comparison to this experiment
(Figure 7D). This was reassuring because it meant that the same
core pathway generalized well for two completely different kinds
of input. In these two experiments the stimulus andmodel system
are the same, but there is a difference in dose. Even allowing
for differences in effective dose, the simulation cannot fit both
of these. As discussed above, the FindSim framework provides
for a user-defined scoring scheme for each experiment, so that
broader considerations can factor into how the user weights each
experiment.
Finally, for Ca2+ input we asked if the model could replicate
the qualitative behavior of sustained activity, that had been
predicted in an earlier modeling study (Bhalla and Iyengar,
1999). Again, this activated a large number of distinct input
stages but the core MAPK pathway was able to replicate the
previous behavior of switching to a state of sustained high activity
following three calcium pulses which corresponded to three
tetanic stimuli used for LTP induction (Figure 7E). Overall,
this exercise showed the efficacy of the FindSim framework
in testing model reproducibility across quite different stimulus
conditions.
DISCUSSION
We have developed FindSim, a framework for systematic,
data-driven construction of large biologically detailed models
of neuronal signaling. The key advances are: (1) A simulation
pipeline that combines a database of structured experimental
data with each model, to systematically generate scores of how
well the model fits the entire dataset. (2) A way to systematically
specify and extract small sub-parts of the full model upon
which to carry out these simulated experiments. Together
with the underlying Python-driven MOOSE simulation engine
for multiscale models, this framework is an open, standards-
driven, and scalable approach to developing reliable, large-scale
models.
Big Models and Biological Problems
It is widely accepted that complex biological pathways
benefit from structured modeling approaches to address
the many routes by which signals flow between stimuli and
physiological outcomes (Kitano, 2002; Hunter and Borg,
2003). This is particularly relevant for complex neurogenetic
diseases such as autism, where mutations in key signaling
components cause ramifying perturbations in many pathways.
The complexity of this problem is exacerbated by cellular
homeostasis mechanisms, which may lead to partial rescue
of some symptoms, but not others. The expectation is that as
models begin to incorporate the relevant range of pathways,
these outcomes may be better understood. Further, such
models would be excellent platforms upon which to conduct
tests of possible pharmacological and other manipulations
with the goal of suggesting treatments (Rajasethupathy et al.,
2005).
Correctness of Big Models
A common criticism of big models, dating from the von
Neumann tradition, is that they have somany parameters that the
modeler could do anything (such as fit an elephant) with them.
Here we first explain how the current model building pipeline
counters this criticism. We then point to two ways in which
the details embedded in a big model improve its testability and
utility.
The modeling framework described in this study provides a
systematic way to avoid the problems ofmulti-parametermodels.
Here we have formalized how multiple experiments map to
different parts of the model. Further, this formalization facilitates
parameterization, and testing, from individual reactions, to
multi-pathway cascades. By testing the models at many scales of
function, this approach is able to ensure not only that individual
pathways work as observed, but that they work together in
a manner consistent with experiment. This process has been
adopted, albeit in a more free-form manner, for other large
models (Bhalla and Iyengar, 1999; Karr et al., 2012).
There are two key positive aspects that large, detailed models
bring to ascertaining correctness. The first is that there is a
clear, usually one-to-one mapping between experimental entities
(molecules, reactions) and their model counterparts. Thus,
there is no ambiguity about what each readout represents.
The second major positive of detail is that the curse of the
abstract model—that it may abstract away essential functional
detail—is avoided. A further, empirically noted corollary of
having biologically detailed models is that they tend to
partake of similar kinds of functional robustness as their
biological counterparts (Morohashi et al., 2002). In biology
this means that minor fluctuations in metabolism or protein
distribution has little functional effect. In the model this
brings the additional benefit that it tends to behave well
even if the parameters are, inevitably, somewhat off. Thus,
the methodology of the current study is designed to allow
principled construction of large, detailed models that avoid the
major drawbacks of such models, while benefiting from their
advantages.
Big Data and Big Models
Our appreciation for biological complexity has risen steeply with
the flood of large-scale data. As an example in neuronal signaling,
we now know the identities of some 1500 postsynaptic proteins
(Bayés et al., 2011), but our understanding of synaptic function
has not kept pace with this explosion of data. Models have
long been tools for understanding complex systems, as well as
predicting their properties in health and disease (Kitano, 2002;
Rajasethupathy et al., 2005). A systematic alignment of big data
to developing big models is therefore highly desirable. One of the
major problems with doing this is that a large fraction of current
experiments is better at providing model constraints rather than
model parameters. A model constraint is an observation that the
model must satisfy, but it does not always yield easily usable
data for improving the model. For improving models, one needs
experiments that more directly provide parameters.
Automated parameter estimation and tuning is important
for developing large, complex models. The current framework
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is designed to efficiently run many simulated experiments on a
model, and this is of obvious utility for parameter estimation and
tuning. This is a complex and well-studied topic (Chou and Voit,
2009; Geier et al., 2012; Sun et al., 2012) and is out of scope of the
current report. A key feature of the FindSim framework is that
every run computes a score of how well the model output fits the
experiment. Effective scoring is itself closely linked to details of
parameter optimization. Here we simply give the user freedom
to specify arbitrary mathematical expressions for comparison
of model output to experimental output, including error bars
(example scoring formula in Figure 5E). This expression can
also include less-tangible scaling factors based on the judgment
of the team implementing the test, such as the reliability of the
experimental approach, or whether the experimental system was
a mouse or a rat.
Model constraints typically arise from remote input-output
relationships. A peculiarity of biological signaling systems is that
very long chains of elementary events, such as reactions, may
link stimulus and response. For example, long-term potentiation
(LTP), which is the staple of synaptic plasticity studies, is
mechanistically separated from synaptic input patterns by at least
the following steps: presynaptic calcium events, neurotransmitter
release, synaptic channel opening, calcium influx, activation of
kinase pathways, protein synthesis and receptor translocation
(Bliss and Collingridge, 1993). Each of these steps may involve
numerous biophysical events and chemical reactions. Yet at
an observational level, LTP is reliable, easily measured, and
well characterized. It is an excellent model constraint. From a
modeling viewpoint, there are far more ‘‘good’’ experiments on
LTP, than there are measurements of mechanisms of just one
of its steps: dendritic protein synthesis. Big data is therefore of
limited value for big models unless the experiments are designed
to home in on, and parameterize, finer mechanistic steps. In
the context of our modeling pipeline, experiments on small
pathways are better for parameterization, including the use of
optimization. Long-pathway experiments tell us what the overall
model should do, but don’t directly help us refine it. Thus,
our data-model development framework defines the kinds of
big data that are of most relevance to constructing reliable, big
models.
Scalability
The current report describes the core concepts and
implementation of a first level modelling and data organization
effort for models of neuronal signaling. The approach is designed
to be scalable both in the kinds of problems it can take on, and in
the technical capabilities it brings to the table.
The current framework was designed around studies of
autism spectrum disorders, with the technical aim of building
sufficiently detailed models so as to be able to match up with the
wide range of current data. Thus only a few models were initially
envisioned: a control model, and a few with known disease-
causing mutations. The approach is readily extended to many
other neurodevelopmental and other diseases provided there are
clear molecular signatures of the signaling deficit in each case.
An obvious further extension of the approach is to apply
it to different cell-types, and in parallel to develop experiment
libraries to parameterize them. In addition to neurons, it would
be interesting to model glia, and then proceed to making models
not just of individual neurons but small groupings of strongly
coupled cells in neural tissue.
Scalability can also be envisaged as extending the experiment-
model interplay to different physical processes. From the
viewpoint of neuronal function, it is clearly important to also
consider the domain of electrical activity of neurons. A few
simulators (e.g., NEURON, MOOSE, STEPS) are now able to
simultaneously model electrical and chemical signaling, but each
has different ways to specify such multiscale models (Ray and
Bhalla, 2008; Wils and De Schutter, 2009; McDougal et al.,
2013). There are efforts to broaden model standards to include
chemical as well as electrical signaling (Cannon et al., 2014).
While the evolution of the FindSim framework to such models
is beyond the scope of the current article, as proof of principle
we illustrate the use of the FindSim format on the Hodgkin-
Huxley model of an action potential4. This requires very minor
extensions within the framework of a time-series experiment.
We anticipate that an important direction for the FindSim
framework will be to support multiscale experiments that
synthesize electrophysiological stimuli with multiple signaling
and physiological readouts.
A further aspect of scalability is the ability of this framework
to host competing models, in the sense that models are
hypotheses of neuronal signaling function. Here the value of the
open experimental database becomes evident. Different groups
can readily re-assign weights and scoring terms for different
experiments, to developmodels that better fit their interpretation
of the experimental literature. The expectation is that such
competing models would spur the execution of more definitive
experiments to decide between the alternatives, and thus advance
the field.
On the technical side, there are clear directions with respect to
the evolution of the experiment specification format, including
standards development for storing them in databases.
The current experiment specification is set up through a
spreadsheet and stored in tab-separated value (tsv) format.
Clearly a more flexible and powerful format would be desirable
as we scale up to much larger models and datasets. We
have considered extensions to the extant SED-ML standard
(Waltemath et al., 2011) as one possible way to define the
experiments. Another alternative may be JSON and its associated
schema (Crockford, 2006). Each of these is also much better
suited to being handled in a database. On the interface front
it would be desirable to develop a browser-based graphical
interface to the model/experiment building pipeline, where the
runs may be hosted in the cloud. These all lend themselves to
incorporation into the FindSim framework. In summary, the
FindSim framework is a principled, scalable framework that
lends itself to reproducibly integrating experiments with complex
multiscale models of neuronal signaling systems.
The FindSim framework currently relies on human
interactions between modelers and experimentalists for the
‘‘model mapping’’ (part 5 of the pipeline). This was a conscious
4https://github.com/BhallaLab/FindSim
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choice on our part. This stage of the framework is an ideal place
for encouraging interaction between human experts, since this is
a stage that relies on expert judgment on what the various parts
of a model and of an experiment mean. In terms of scalability,
this may be a bottleneck. Indeed, other initiatives have aimed
at automating similar processes (Cooper et al., 2011; Alm et al.,
2015; Neal et al., 2015). It should be noted, however, that those
automations depend on high-quality annotations. As such, they
do not eliminate the need for human curation, it just happens at
a different stage of the process (model/data annotation). Which
of those two approaches is ultimately better scalable, and to
what extent the expert annotation component can be automated,
remains an interesting avenue for future research.
DATASETS
The datasets and code used for this study can be found in
https://github.com/BhallaLab/FindSim. The MOOSE simulator
is hosted at https://moose.ncbs.res.in/ and on https://github.
com/BhallaLab/moose.
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